Public Citizen Seeks Iressa Withdrawal From Market
This article was originally published in The Pink Sheet Daily
Executive Summary
Public Citizen's Health Research Group is calling for FDA to withdraw licensure of AstraZeneca's epidermal growth factor receptor inhibitor Iressa